Dr. Arthur DeCarlo, Bonenta's founder, President, and current CEO, received his Ph.D. training and medical specialty training at the University of Alabama in Birmingham under world-class mentorship.
has spent 23 years acquiring expertise in surgical clinical medicine, biochemistry, genetics, microbiology, and immunological research and has a proven experience in conveying the scientific knowledge and information necessary to garner peer-reviewed research approvals, funding awards and publications.
Dr. DeCarlo has also spent several years on committees that oversee research in human subjects (IRB and Clinical Trial Safety Review Board), has directed pre-clinical and human clinical research, and chaired university health professions research activities.
International experience has provided a broader scientific perspective to an already award-winning research career.
participated in the NIH
Commercialization Accelerator Program (CAP) program in 2008-09.
Dr. Whitelock and Dr. DeCarlo
discuss data monthly and meet annually.
Dr. Chambers and Dr. DeCarlo
have also worked well together in the past, exchanging ideas freely.
A pre-IND meeting will be scheduled immediately following a financing event and will be attended by Dr. DeCarlo
and Lindsay Donald.